Walleye Capital LLC Amylyx Pharmaceuticals, Inc. Transaction History
Walleye Capital LLC
- $23.6 Billion
- Q2 2025
Shares
12 transactions
Others Institutions Holding AMLX
# of Institutions
150Shares Held
74.5MCall Options Held
148KPut Options Held
98.7K-
Perceptive Advisors LLC New York, NY7.87MShares$64.6 Million1.17% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.94MShares$48.8 Million5.07% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.7MShares$46.8 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.5MShares$36.9 Million0.0% of portfolio
-
Saturn V Capital Management LLC Austin, TX3.26MShares$26.8 Million8.47% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $481M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...